Accrued Expenses

3 Months Ended

Mar. 31, 2016

7.	ACCRUED EXPENSES

Accrued expenses consisted of the following:

	March 31,		December 31,
	2016		2015
Accrued clinical operations and trials costs	$	1,028,181	$	365,188
Accrued product development costs		141,756		152,018
Accrued audit fees		60,000		16,500
Accrued other		68,051		28,573
Total	$	1,297,988	$	562,279